Here are five things you must know for Tuesday, Nov. 19:
1. -- Stock Futures Point to Fresh Record Highs for Wall Street
U.S. stock futures were higher Tuesday though conflicting signals remained for a near-term U.S.-China trade agreement. A decline in shares of Home Depot (HD) - Get Report , which cut its full-year sales forecast, also weighed on markets.
Reports of increasing pessimism from senior Chinese officials for the willingness of Donald Trump to roll back tariffs in the event of an interim trade pact have added to concerns that negotiations may have stalled. However, the U.S. decision to grant a 90-day extension to American companies doing business with China's Huawei Technologies suggests the administration has adopted a flexible stance toward dealing with Beijing.
"Risk sentiment can be seen little changed amid the conflicting reports on US-China trade as we remain in a very headline driven reality," said Jingyi Pan, market strategist at IG in Singapore.
U.S. stocks looked poised Tuesday to post fresh record highs for a third consecutive session. Contracts tied to the Dow Jones Industrial Average rose 39 points, futures for the S&P 500 were up 7.20 points, and Nasdaq futures rose 34.50 points.
The three major U.S. stock benchmarks recorded all-time closing highs Monday The Dow rose 0.1% to close at 28,036, and the S&P 500 gained 0.05% to 3,122. The Nasdaq finished up 0.1% to 8,549.
2. -- Earnings From Home Depot and Kohl's, Housing Starts Are Tuesday's Highlights
Home Depot (HD) - Get Report posted third-quarter earnings of $2.53 a share, beating analysts' estimates by 1 cent, but the stock sank 4.75% in premarket trading to $227.50 after the company missed sales estimates and lowered its fiscal-year sales guidance.
The economic calendar in the U.S. Tuesday includes Housing Starts for October at 8:30 a.m. ET.
New York Federal Reserve Bank President John Williams is scheduled to speak at the Securities Industry and Financial Markets Association's annual meeting in Washington at 9 a.m.
3. -- Boeing Books $3.6 Billion in New Orders for 737 MAX
Boeing (BA) - Get Report booked $3.6 billion in new orders for its 737 MAX jet at the Dubai Airshow as the world's biggest planemaker continues to estimate a potential return in December for the grounded aircraft.
Boeing said Kazakhstan-based Air Astana plans to purchase 30 737 MAX 8 planes to service its low-cost airline FlyArystan. List prices for the jets put the order at around $3.6 billion, although carriers will often negotiate discounts on bulk orders that reduce the total cost. Turkey's SunExpress, another discount European carrier, said Monday it will exercise options for 10 additional Boeing 737 MAX 8 airplanes in a $1.2 billion deal.
"Air Astana has become one of the leading airlines in Central Asia with its deep focus on safety, reliability, efficiency and customer service. At Boeing, we share those same values and are honored to expand our partnership with the 737 MAX," said Stan Deal, CEO of Boeing Commercial Airplanes. "We believe the efficiency and reliability built into the 737 MAX will be a great fit for FlyArystan.
The new orders followed Boeing's estimate last week of a mid-December return to service for the 737 MAX, which was grounded last spring following crashes in Ethiopia and Indonesia that killed 346 people, although Deal told reporters Saturday that a firm return date was up to regulators at the Federal Aviation Administration.
4. -- Salesforce's Annual Dreamforce Convention Begins Tuesday
Co-CEOs Marc Benioff and Keith Block will deliver the opening keynote on Tuesday at 1 p.m. ET, outlining the vision for the event and for Salesforce's current priorities. In addition to a number of Salesforce executives and customers, various luminaries from the tech world and beyond are due to speak at the event, including Apple (AAPL) - Get Report CEO Tim Cook and former President Barack Obama.
Salesforce management also is due to meet with investors and analysts on Wednesday and into Thursday.
BMO Capital Markets analyst Keith Bachman said that Salesforce's margins are likely to be an area of focus, given the company's string of big-ticket purchases over the past several months, while investors also will like to hear about the trade-off between Salesforce's core business and its acquisition strategy, TheStreet's Annie Gaus wrote.
5. -- Medicines Co. Reportedly Attracts Takeover Interest From Suitors Such as Novartis
Novartis has been holding talks about a potential acquisition of Medicines Co., a developer of a promising cholesterol drug, the people said. Novartis, the Swiss drugmaker, is conducting due diligence on the company
Other potential acquirers also have expressed interest in an acquisition of Medicines Co., and there's no certainty an agreement will be reached, the people told Bloomberg
Shares of Medicines Co. were rising 17.65% to $69 in premarket trading. The stock has gained more than 206% so far this year.